Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy

The prevalence of inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, in Canada, is over 0.75% in 2021. Many individuals with IBD are immunocompromised. Consequently, the World Health Organization’s declaration of a global pandemic uniquely impacted those with IBD. Crohn’s and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Gilaad G, Windsor, Joseph W, Crain, Janet, Barrett, Lisa, Bernstein, Charles N, Bitton, Alain, Chauhan, Usha, Coward, Stephanie, Fowler, Sharyle, Ghia, Jean-Eric, Gibson, Deanna L, Griffiths, Anne M, Jones, Jennifer L, Khanna, Reena, Kuenzig, M Ellen, Lakatos, Peter L, Lee, Kate, Mack, David R, Marshall, John K, Mawani, Mina, Murthy, Sanjay K, Panaccione, Remo, Seow, Cynthia H, Targownik, Laura E, Zelinsky, Sandra, Benchimol, Eric I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570425/
https://www.ncbi.nlm.nih.gov/pubmed/34755034
http://dx.doi.org/10.1093/jcag/gwab028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570425/
https://www.ncbi.nlm.nih.gov/pubmed/34755034
http://dx.doi.org/10.1093/jcag/gwab028

Ejemplares similares